These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31358467)

  • 21. Design, Synthesis, Antifungal Activity and Molecular Docking of Thiochroman-4-one Derivatives.
    Zhong Y; Han X; Li S; Qi H; Song Y; Qiao X
    Chem Pharm Bull (Tokyo); 2017; 65(10):904-910. PubMed ID: 28966274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrimidinetrione-imidazoles as a Unique Structural Type of Potential Agents towards Candida Albicans: Design, Synthesis and Biological Evaluation.
    Sui YF; Ansari MF; Zhou CH
    Chem Asian J; 2021 Jun; 16(11):1417-1429. PubMed ID: 33829660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14alpha-demethylase (CYP51) of fungi.
    Zhu J; Lu J; Zhou Y; Li Y; Cheng J; Zheng C
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5285-9. PubMed ID: 16905318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of new fluconazole analogues.
    Pore VS; Agalave SG; Singh P; Shukla PK; Kumar V; Siddiqi MI
    Org Biomol Chem; 2015 Jun; 13(23):6551-61. PubMed ID: 25975803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and SAR study of 3-(benzo[d][1,3]dioxol-5-yl)-N-benzylpropanamide as novel potent synergists against fluconazole-resistant Candida albicans.
    Cai Z; Ding Z; Hao Y; Ni T; Xie F; Zhao J; Li R; Yu S; Wang T; Chai X; Jin Y; Gao Y; Zhang D; Jiang Y
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4571-4575. PubMed ID: 28874321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as potent antifungal agents: new insights into structure-activity relationships.
    Guillon R; Pagniez F; Rambaud C; Picot C; Duflos M; Logé C; Le Pape P
    ChemMedChem; 2011 Oct; 6(10):1806-15. PubMed ID: 21748853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors.
    Sun B; Dong Y; Lei K; Wang J; Zhao L; Liu M
    Bioorg Med Chem; 2019 Jun; 27(12):2427-2437. PubMed ID: 30765301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
    J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis and antifungal activity of 1-(1,2,4-triazolyl-1H-1-yl)-2-(2,4-diflurophenyl)-3-(4-substituted benzyl-1-piperazinyl)-2-propanols].
    Sheng CQ; Zhang WN; Ji HT; Song YL; Yang S; Zhou YJ; Zhu J; Lü JG
    Yao Xue Xue Bao; 2003 Sep; 38(9):665-70. PubMed ID: 14730915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
    Chai X; Zhang J; Yu S; Hu H; Zou Y; Zhao Q; Dan Z; Zhang D; Wu Q
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1811-4. PubMed ID: 19231179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
    Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
    Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antifungal activity of new thienyl and aryl conazoles.
    Chevreuil F; Landreau A; Seraphin D; Larcher G; Bouchara JP; Richomme P
    J Enzyme Inhib Med Chem; 2006 Jun; 21(3):293-303. PubMed ID: 16918077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
    Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT
    J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues.
    Chen SH; Sheng CQ; Xu XH; Jiang YY; Zhang WN; He C
    Biol Pharm Bull; 2007 Jul; 30(7):1246-53. PubMed ID: 17603162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
    Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of novel diazaspiro[4.5]decan-1-one derivatives as potential chitin synthase inhibitors and antifungal agents.
    Li B; Wang K; Zhang R; Li B; Shen Y; Ji Q
    Eur J Med Chem; 2019 Nov; 182():111669. PubMed ID: 31494473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
    Yao B; Ji H; Cao Y; Zhou Y; Zhu J; Lü J; Li Y; Chen J; Zheng C; Jiang Y; Liang R; Tang H
    J Med Chem; 2007 Nov; 50(22):5293-300. PubMed ID: 17900179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of new 1-[2-Azido-2-(2,4-dichlorophenyl)ethyl]-1H/-imidazoles and in vitro evaluation of their antifungal activity.
    Chevreuil F; Landreau A; Seraphin D; Larcher G; Bouchara JP; Richomme P
    J Enzyme Inhib Med Chem; 2008 Oct; 23(5):617-22. PubMed ID: 18821251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.